Nevertheless, the ability to alter macrophage polarization via CD44 offers a potentially new mechanism to target the inflammatory response in vivo, in the context of tumor progression as well as other inflammatory conditions, such as wound healing, lung injury, and atherosclerosis. This evidence concerns the gene CD44 and atherosclerosis.